Complete Comparison: Every Dose, Every Difference
Mounjaro or Wegovy: Complete Dose Journey Comparison
When deciding between Mounjaro or Wegovy, understanding the complete dose escalation is crucial for long-term success. Both medications require gradual dose increases, but their schedules and mechanisms differ significantly. Wegovy (semaglutide) follows a structured 16-week escalation: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, then 2.4mg maintenance from week 17 onwards. Mounjaro (tirzepatide) uses a similar timeframe but with different dose strengths, reflecting its dual GIP+GLP-1 mechanism versus Wegovy's GLP-1-only approach.
At EverydayMeds, we stock every dose of both treatments, ensuring patients never face supply interruptions during their weight management journey. This complete availability means your prescriber can choose the most appropriate medication based on your individual response, medical history, and tolerability. Our clinical team understands that some patients may need to stay on lower doses longer, while others progress smoothly through the escalation—having every dose available provides maximum flexibility.
Pricing Comparison: Wegovy vs Mounjaro All Doses Available
Understanding the cost implications when choosing between Mounjaro or Wegovy requires examining pricing across the complete dose range. Wegovy pricing at EverydayMeds starts with 0.25mg at £79.99, progressing to 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and maintenance 2.4mg at £209.99. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 to reach these final prices. Our bundle options provide convenience for longer-term planning, with the Intro Trio (0.25mg, 0.5mg, 1mg) at £299.99 covering your first 12 weeks of treatment.
The Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99, eliminating the need for monthly orders once you reach your optimal dose. This pricing structure reflects the increasing cost as doses rise, typical for both Wegovy and Mounjaro across all UK suppliers. Having transparent pricing for every dose helps patients budget for their complete treatment journey, whether they're comparing initial costs or planning for long-term maintenance therapy.
Clinical Evidence: Mounjaro vs Wegovy Treatment Outcomes
When comparing Mounjaro or Wegovy clinically, both demonstrate significant efficacy in their respective trials, though direct head-to-head comparisons are limited. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial, as reported by Wilding et al., NEJM, 2021. The STEP programme also showed sustained results at 2 years, with patients maintaining significant weight reduction when continuing treatment.
Mounjaro's clinical programme demonstrates its dual GIP+GLP-1 mechanism may offer additional benefits beyond traditional GLP-1 therapy alone. However, comparing trial percentages directly isn't appropriate due to different study designs, populations, and endpoints. Both medications are prescription-only medicines that require clinical assessment and ongoing monitoring, with individual results varying based on adherence to diet and exercise recommendations.
Mechanism Differences: How Wegovy Works Compared to Mounjaro
Understanding mechanism differences is essential when deciding between Mounjaro or Wegovy for your weight management goals. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, reducing appetite and promoting satiety after smaller meals. This once-weekly injectable medication may also reduce food cravings by working on brain appetite centres, helping patients feel satisfied with reduced portion sizes. The GLP-1 mechanism slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged feelings of fullness. Wegovy's established GLP-1 pathway has extensive clinical evidence and is well-understood by healthcare providers.
Ordering Process: Getting Started with Either Treatment
Whether you choose Mounjaro or Wegovy after consulting with our prescribers, EverydayMeds streamlines the process with our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our GPhC-registered prescribers review applications within 3 working days (or 24 hours with express service), ensuring thorough evaluation before prescribing either treatment. Once approved, your medication ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. All pens arrive in temperature-controlled packaging with clear injection instructions and dose escalation guidance. Our clinical team remains available throughout your treatment for any questions about your chosen medication.
Storage and Practical Considerations
Storage requirements can influence your choice between Mounjaro or Wegovy, especially for frequent travellers or those with limited fridge space. Wegovy offers a significant practical advantage with 6 weeks of room temperature stability below 30°C once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. Both require initial refrigerated storage at 2-8°C, but Wegovy's extended room temperature tolerance provides greater flexibility for holidays, business trips, or unexpected situations. The FlexTouch pen design used for Wegovy is intuitive and reliable, with clear dose displays and smooth injection mechanisms. This storage advantage, combined with our complete dose availability, makes treatment continuation more manageable throughout your weight management journey.
Complete Treatment Journey: Why All Doses Matter
Having access to every dose when comparing Mounjaro or Wegovy becomes crucial during your treatment progression, as individual responses vary significantly. Some patients tolerate rapid dose escalation, while others need extended time at lower doses to minimise side effects like nausea or digestive discomfort. EverydayMeds stocks every strength, allowing your prescriber to personalise your escalation timeline based on your body's response rather than supply limitations. This flexibility prevents treatment interruptions that could compromise your progress.
Our Ultimate Stability Trio and other maintenance bundles recognise that successful weight management extends far beyond the initial months, requiring reliable supply of your optimal dose. Whether you settle on 1mg, 1.7mg, or the full 2.4mg maintenance dose, having assured access eliminates the anxiety of supply shortages. This comprehensive approach means EverydayMeds becomes your long-term partner, not just your starting point.
Making Your Choice: Expert Prescriber Guidance Available
The decision between Mounjaro or Wegovy ultimately depends on individual factors including your medical history, previous treatment responses, lifestyle considerations, and cost preferences. Both medications are available through EverydayMeds with complete prescriber support to help determine which treatment aligns best with your circumstances. Our clinical assessment considers your specific needs, ensuring appropriate medication selection and monitoring throughout your weight management journey. Starting with code FIRST40 for new customers or DOSE25 for returning patients, you can begin either treatment with confidence in our complete dose availability. Contact our clinical team to discuss which option may be most suitable for your individual situation, backed by our GPhC registration #9012878.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
